[HTML][HTML] Terminal complement pathway activation drives synaptic loss in Alzheimer's disease models
Complement is involved in developmental synaptic pruning and pathological synapse loss
in Alzheimer's disease. It is posited that C1 binding initiates complement activation on …
in Alzheimer's disease. It is posited that C1 binding initiates complement activation on …
Contribution of Neurons and Glial Cells to Complement‐Mediated Synapse Removal during Development, Aging and in Alzheimer's Disease
C Luchena, J Zuazo-Ibarra, E Alberdi… - Mediators of …, 2018 - Wiley Online Library
Synapse loss is an early manifestation of pathology in Alzheimer's disease (AD) and is
currently the best correlate to cognitive decline. Microglial cells are involved in synapse …
currently the best correlate to cognitive decline. Microglial cells are involved in synapse …
[HTML][HTML] Insight into the role of phosphatidylserine in complement-mediated synapse loss in Alzheimer's disease
The innate immune system plays an integral role in the brain. Synaptic pruning, a
fundamental process in developmental circuit refinement, is partially mediated by …
fundamental process in developmental circuit refinement, is partially mediated by …
[HTML][HTML] Complement C3 is activated in human AD brain and is required for neurodegeneration in mouse models of amyloidosis and tauopathy
T Wu, B Dejanovic, VD Gandham, A Gogineni… - Cell reports, 2019 - cell.com
Complement pathway overactivation can lead to neuronal damage in various neurological
diseases. Although Alzheimer's disease (AD) is characterized by β-amyloid plaques and tau …
diseases. Although Alzheimer's disease (AD) is characterized by β-amyloid plaques and tau …
Complement-mediated synapse loss in Alzheimer's disease: mechanisms and involvement of risk factors
L Wen, D Bi, Y Shen - Trends in Neurosciences, 2024 - cell.com
The complement system is increasingly recognized as a key player in the synapse loss and
cognitive impairments observed in Alzheimer's disease (AD). In particular, the process of …
cognitive impairments observed in Alzheimer's disease (AD). In particular, the process of …
[HTML][HTML] Complement-associated loss of CA2 inhibitory synapses in the demyelinated hippocampus impairs memory
V Ramaglia, M Dubey, MA Malpede, N Petersen… - Acta …, 2021 - Springer
The complement system is implicated in synapse loss in the MS hippocampus, but the
functional consequences of synapse loss remain poorly understood. Here, in post-mortem …
functional consequences of synapse loss remain poorly understood. Here, in post-mortem …
Complement C3 and C4 expression in C1q sufficient and deficient mouse models of Alzheimer's disease
J Zhou, MI Fonseca, K Pisalyaput… - Journal of …, 2008 - Wiley Online Library
Alzheimer's disease (AD) is a neurodegenerative disease resulting in progressive cognitive
decline. Amyloid plaque deposits consisting specifically of β‐amyloid peptides that have …
decline. Amyloid plaque deposits consisting specifically of β‐amyloid peptides that have …
Local apoptotic-like mechanisms underlie complement-mediated synaptic pruning
C1q, a member of the immune complement cascade, is implicated in the selective pruning of
synapses by microglial phagocytosis. C1q-mediated synapse elimination has been shown …
synapses by microglial phagocytosis. C1q-mediated synapse elimination has been shown …
Complement system in neural synapse elimination in development and disease
J Presumey, AR Bialas, MC Carroll - Advances in immunology, 2017 - Elsevier
Recent discoveries implicate the classical complement cascade in normal brain
development and in disease. Complement proteins C1q, C3, and C4 participate in synapse …
development and in disease. Complement proteins C1q, C3, and C4 participate in synapse …
[HTML][HTML] Contribution of complement activation pathways to neuropathology differs among mouse models of Alzheimer's disease
MI Fonseca, SH Chu, AM Berci, ME Benoit… - Journal of …, 2011 - Springer
Background Complement proteins and activation products have been found associated with
neuropathology in Alzheimer's disease (AD). Recently, a C5a receptor antagonist was …
neuropathology in Alzheimer's disease (AD). Recently, a C5a receptor antagonist was …